
UB360
TargetsP2Y12R
IndicationsPeripheral arterial disease
ClinicalUS - NDA
TherapeuticsCardiovascular
ModalitiesSmall Molecule
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →